source · text/csv
source_a31fb6d38d6f4328
sha256 294e49c28fed1518c2cd81c9f282566f8edf6dc6a0fd30b9cdca96765fc817e7
by researka:v2 · 2026-06-05 05:30:45.992605+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Semaglutide for the treatment of overweight and obesity: A review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "767dd1a7-1300-4f73-8821-ca5a468dbafd",
"researka_submission_id": "c0988830-d72e-4e01-9492-82269d8fd762",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/767dd1a7-1300-4f73-8821-ca5a468dbafd/sidecars/evidence_table.csv"
}